Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody 2021-07-09 21:00
Sequanta and Mission Bio announce strategic partnership 2021-07-09 15:44
BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer 2021-07-08 12:01
Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis 2021-07-06 21:06
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD 2021-07-06 18:00
Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology 2021-07-01 21:00
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies 2021-06-30 09:29
Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide" 2021-06-29 21:00
I-Mab Announces Upcoming Participation at July Conference 2021-06-29 20:00
First in China! Neurophth announced the first patient has been dosed in G.O.L.D. clinical trial for the gene therapy treatment of LHON 2021-06-28 21:33
International experts join Microba Life Sciences inaugural IBD Advisory Panel 2021-06-28 21:00
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury 2021-06-28 20:00
InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL 2021-06-28 16:02
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery 2021-06-26 23:00
World-first predictive test for Diabetic Kidney Disease could save $384 billion over 10 years 2021-06-25 23:30
Vazyme Brings COVID-19 Testing Solutions at Medlab 2021 2021-06-25 15:31
Research showed that InxMed FAK Inhibitor (IN10018) Overcomes Drug Resistance of KRAS G12C inhibitors and Synergizes with KRAS G12C inhibitors in Treating Cancer 2021-06-25 15:06
Samsung Biologics Issues Its First Annual Sustainability Report 2021-06-25 09:01
TCI JAPAN Launched its Breakthrough, SCIENCE OF PROBIOTICS, Demonstrating How to Keep Probiotics Alive without Refrigeration for over 1 year 2021-06-25 09:00
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections 2021-06-23 19:28
1 110 111 112 113 114 228